Benitec Biopharma Ltd Stock Volatility

BNTC Stock  USD 6.86  0.14  2.08%   
Benitec Biopharma is very risky given 3 months investment horizon. Benitec Biopharma secures Sharpe Ratio (or Efficiency) of 0.21, which signifies that the company had a 0.21% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.61% are justified by taking the suggested risk. Use Benitec Biopharma Mean Deviation of 4.32, downside deviation of 5.53, and Risk Adjusted Performance of 0.1406 to evaluate company specific risk that cannot be diversified away. Key indicators related to Benitec Biopharma's volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
Benitec Biopharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Benitec daily returns, and it is calculated using variance and standard deviation. We also use Benitec's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Benitec Biopharma volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Benitec Biopharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Benitec Biopharma at lower prices. For example, an investor can purchase Benitec stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Benitec Biopharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Benitec Stock

  0.83VKTX Viking Therapeutics Earnings Call TodayPairCorr
  0.84ELEV Elevation Oncology Financial Report 20th of May 2024 PairCorr
  0.69XFOR X4 Pharmaceuticals Financial Report 2nd of May 2024 PairCorr

Moving against Benitec Stock

  0.69GILD Gilead Sciences Earnings Call TomorrowPairCorr
  0.48JNJ Johnson Johnson Aggressive PushPairCorr
  0.44PFE Pfizer Inc Earnings Call This WeekPairCorr

Benitec Biopharma Market Sensitivity And Downside Risk

Benitec Biopharma's beta coefficient measures the volatility of Benitec stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Benitec stock's returns against your selected market. In other words, Benitec Biopharma's beta of 0.95 provides an investor with an approximation of how much risk Benitec Biopharma stock can potentially add to one of your existing portfolios. Benitec Biopharma Ltd is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Benitec Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Benitec Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Benitec Biopharma Demand Trend
Check current 90 days Benitec Biopharma correlation with market (NYSE Composite)

Benitec Beta

    
  0.95  
Benitec standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  7.71  
It is essential to understand the difference between upside risk (as represented by Benitec Biopharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Benitec Biopharma's daily returns or price. Since the actual investment returns on holding a position in benitec stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Benitec Biopharma.

Benitec Biopharma Stock Volatility Analysis

Volatility refers to the frequency at which Benitec Biopharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Benitec Biopharma's price changes. Investors will then calculate the volatility of Benitec Biopharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Benitec Biopharma's volatility:

Historical Volatility

This type of stock volatility measures Benitec Biopharma's fluctuations based on previous trends. It's commonly used to predict Benitec Biopharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Benitec Biopharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Benitec Biopharma's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Benitec Biopharma Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Benitec Biopharma Projected Return Density Against Market

Given the investment horizon of 90 days Benitec Biopharma has a beta of 0.9524 suggesting Benitec Biopharma Ltd market returns are highly-sensitive to returns on the market. As the market goes up or down, Benitec Biopharma is expected to follow.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Benitec Biopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Benitec Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Benitec stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Benitec Biopharma Ltd has an alpha of 1.4984, implying that it can generate a 1.5 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Benitec Biopharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how benitec stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Benitec Biopharma Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Benitec Biopharma Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Benitec Biopharma is 477.43. The daily returns are distributed with a variance of 59.45 and standard deviation of 7.71. The mean deviation of Benitec Biopharma Ltd is currently at 4.46. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α
Alpha over NYSE Composite
1.50
β
Beta against NYSE Composite0.95
σ
Overall volatility
7.71
Ir
Information ratio 0.20

Benitec Biopharma Stock Return Volatility

Benitec Biopharma historical daily return volatility represents how much of Benitec Biopharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 7.7101% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6321% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Benitec Biopharma Volatility

Volatility is a rate at which the price of Benitec Biopharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Benitec Biopharma may increase or decrease. In other words, similar to Benitec's beta indicator, it measures the risk of Benitec Biopharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Benitec Biopharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Market Cap6.5 M6.1 M
Benitec Biopharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Benitec Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Benitec Biopharma's price varies over time.

3 ways to utilize Benitec Biopharma's volatility to invest better

Higher Benitec Biopharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Benitec Biopharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Benitec Biopharma stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Benitec Biopharma investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Benitec Biopharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Benitec Biopharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Benitec Biopharma Investment Opportunity

Benitec Biopharma Ltd has a volatility of 7.71 and is 12.24 times more volatile than NYSE Composite. 68 percent of all equities and portfolios are less risky than Benitec Biopharma. You can use Benitec Biopharma Ltd to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Benitec Biopharma to be traded at $8.23 in 90 days.

Significant diversification

The correlation between Benitec Biopharma Ltd and NYA is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Benitec Biopharma Ltd and NYA in the same portfolio, assuming nothing else is changed.

Benitec Biopharma Additional Risk Indicators

The analysis of Benitec Biopharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Benitec Biopharma's investment and either accepting that risk or mitigating it. Along with some common measures of Benitec Biopharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Benitec Biopharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Benitec Biopharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Benitec Biopharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Benitec Biopharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Benitec Biopharma Ltd.
When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Benitec Stock analysis

When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Benitec Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(236.13)
Revenue Per Share
0.03
Quarterly Revenue Growth
0.125
Return On Assets
(0.82)
Return On Equity
(1.78)
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.